Provided by Tiger Trade Technology Pte. Ltd.

Denali Therapeutics Inc.

17.07
+0.12000.71%
Volume:1.76M
Turnover:30.03M
Market Cap:2.67B
PE:-5.86
High:17.57
Open:16.98
Low:16.64
Close:16.95
52wk High:24.35
52wk Low:10.57
Shares:156.16M
Float Shares:142.00M
Volume Ratio:1.02
T/O Rate:1.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9114
EPS(LYR):-2.5705
ROE:-44.44%
ROA:-27.29%
PB:2.88
PE(LYR):-6.64

Loading ...

Denali Therapeutics Coverage Assumed by UBS at Buy

Dow Jones
·
Yesterday

BRIEF-Denali Therapeutics Announces Key Anticipated Milestones And Priorities For 2026

Reuters
·
Jan 06

Denali Therapeutics reports $872.9 million cash position ahead of key 2026 milestones

Reuters
·
Jan 06

Denali Therapeutics Inc - FDA Lifts Clinical Hold on Dnl952, Phase 1 Study to Proceed

THOMSON REUTERS
·
Jan 06

Denali Therapeutics Inc - Prepares for FDA Approval and Launch of Tividenofusp Alfa

THOMSON REUTERS
·
Jan 06

Denali Therapeutics Announces Key Anticipated Milestones and Priorities for 2026 Including Commercial Launch of Tividenofusp Alfa for Hunter Syndrome

GlobeNewswire
·
Jan 06

Denali Therapeutics Reports Positive Phase 1/2 Results for Tividenofusp Alfa in Hunter Syndrome

Reuters
·
Dec 30, 2025

Does Denali’s $200M Equity Raise And FDA Talks Change The Bull Case For DNLI?

Simply Wall St.
·
Dec 24, 2025

Does Denali Therapeutics' (DNLI) Discounted Equity Raise Reveal a New Phase in Its Risk Strategy?

Simply Wall St.
·
Dec 17, 2025

Denali Therapeutics Shares Fall in Premarket on Share Offering Price

Dow Jones
·
Dec 10, 2025

BRIEF-Denali Therapeutics Says Co Prices Public Offering Of 9.14 Mln Shares At $17.50 Each

Reuters
·
Dec 10, 2025

Denali Therapeutics Inc - Prices Public Offering of 9,142,857 Shares at $17.50 Each

THOMSON REUTERS
·
Dec 10, 2025

BUZZ-Denali Therapeutics slides after launching $200 million share sale

Reuters
·
Dec 10, 2025

Denali Therapeutics: to Offer & Sell $200 Mln of Shares of Its Common Stock and, in Lieu of Common Stock to Certain Investors, Warrants

THOMSON REUTERS
·
Dec 10, 2025

Denali Therapeutics Inc - Grants Underwriters Option for $30 Mln Additional Shares

THOMSON REUTERS
·
Dec 10, 2025

Denali Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire
·
Dec 10, 2025

Denali Flags Minimal Delay After FDA Halts Rare Disease Trial Start

Benzinga_recent_news
·
Dec 06, 2025

Denali Therapeutics, Royalty Pharma Enter $275 Million Royalty Funding Agreement for Hunter Syndrome Treatment

Dow Jones
·
Dec 04, 2025

Denali Therapeutics Inc - Royalty Pharma to Receive 9.25% Royalty on Worldwide Sales of Tividenofusp Alfa From Denali

THOMSON REUTERS
·
Dec 04, 2025

Press Release: Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement

Dow Jones
·
Dec 04, 2025